Back to Search
Start Over
Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.
- Source :
-
Neuro-oncology [Neuro Oncol] 2021 Aug 02; Vol. 23 (8), pp. 1415. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 1523-5866
- Volume :
- 23
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Neuro-oncology
- Accession number :
- 32609812
- Full Text :
- https://doi.org/10.1093/neuonc/noaa115